Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Classificação em ações #20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Preço da ação
$1.91
Valor de mercado
$136.47M
Variação (1 dia)
-1.15%
Variação (1 ano)
21.17%
País
TW
Negociar Sinew Pharma Inc. (6634)

Categoria

EPS de Sinew Pharma Inc. (6634)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Sinew Pharma Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Sinew Pharma Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
- -
CH
$-7.98 -
US